Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22660 | 24378267 | Ann Hepatol | Predictors of chronic liver disease in individuals with human immunodeficiency virus infection. | 2014 | Details |
| A22662 | 24377452 | Nutrition | Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge. | 2014 | Details |
| A22664 | 24376752 | PLoS One | COH-SR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese mice. | 2013 | Details |
| A22666 | 24375485 | Hepatology | Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2013 | Details |
| A22671 | 24373555 | Nutr J | Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. | 2013 | Details |
| A22672 | 24373179 | Diabetes Obes Metab | APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome. | 2014 | Details |
| A22674 | 24372861 | J Gastroenterol Hepatol | Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis. | 2014 | Details |
| A22677 | 27335843 | ISRN Hepatol | The Wide and Complex Field of NAFLD Biomarker Research: Trends. | 2014 | Details |
| A22679 | 26417275 | EXCLI J | Non-alcoholic fatty liver disease, diet and gut microbiota. | 2014 | Details |
| A22680 | 26237264 | J Clin Med | The Impacts of Obesity and Metabolic Abnormality on Carotid Intima-Media Thickness and Non-Alcoholic Fatty Liver Disease in Children from an Inland Chinese City. | 2014 | Details |
| A22681 | 26202413 | Hepatol Int | Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males. | 2014 | Details |
| A22687 | 25937854 | EPMA J | 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics. | 2014 | Details |
| A22690 | 25911909 | Eksp Klin Gastroenterol | [Role of leptin and leptin resistance in non-alcoholic fatty liver disease development in persons with obesity and overweight]. | 2014 | Details |
| A22691 | 25911908 | Eksp Klin Gastroenterol | [Adipokines and liver function in patients with nonalcoholic fatty liver disease, type 2 diabetes mellitus and its combination]. | 2014 | Details |
| A22692 | 25859286 | Clin Epigenetics | Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver disease. | 2014 | Details |
| A22693 | 25842663 | Eksp Klin Gastroenterol | [Prevalence of nonalcoholic fatty liver disease in young patients with abdominal obesity and hypertension]. | 2014 | Details |
| A22694 | 25816629 | Vopr Pitan | [An analysis of the efficacy of low-calorie and isocaloric diets in obese patients with nonalcoholic steatohepatitis]. | 2014 | Details |
| A22695 | 25816621 | Vopr Pitan | [Isomeric specific analysis of hydroxyeicosatetraenoic acid in blood samples from obese patients with non-alcoholic and alcoholic steatohepatitis]. | 2014 | Details |
| A22696 | 25798442 | Front Med (Lausanne) | Knowing What's Out There: Awareness of Non-Alcoholic Fatty Liver Disease. | 2014 | Details |
| A22697 | 25796866 | Wiad Lek | [Variants of the course of non-alcoholic fatty liver disease in patients with ischemic heart disease and possibility of hypolipidemic therapy]. | 2014 | Details |
| A22699 | 25796845 | Wiad Lek | [The use of complex tools ezetimibe, hepadyfu fosinopril and correction of blood pressure and endothelial dysfunction in patients with nonalcoholic steatohepatitis and essential hypertension stage II]. | 2014 | Details |
| A22700 | 25796814 | Wiad Lek | Combined effect of appointment telmisartan and atorvastatin on hemodynamic indicators and the indicators of lipid profile in patients with arterial hypertension combined with obesity and steatohepatitis. | 2014 | Details |
| A22701 | 25790713 | Klin Med (Mosk) | [Association of leptin and total immunoglobulin E in obese patients]. | 2014 | Details |
| A22703 | 25744638 | Nihon Rinsho Meneki Gakkai Kaishi | [Cellular senescence and chronic inflammation]. | 2014 | Details |
| A22711 | 24364104 | Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | [Changes of serum aminotransferase in children with obstructive sleep apnea hypopnea syndrome]. | 2013 | Details |
| A22712 | 24363521 | World J Gastroenterol | Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. | 2013 | Details |
| A22713 | 24363514 | World J Gastroenterol | Cross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatment. | 2013 | Details |
| A22716 | 24361070 | Nutr Metab Cardiovasc Dis | Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis. | 2013 | Details |
| A22725 | 24355322 | Surg Obes Relat Dis | Laparoscopic sleeve gastrectomy in patients with NASH-related cirrhosis: a case-matched study. | 2013 | Details |
| A22728 | 24353111 | Biofactors | Novel insights on interactions between folate and lipid metabolism. | 2013 | Details |
| A22737 | 24345846 | J Pediatr Gastroenterol Nutr | A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease. | 2014 | Details |
| A22738 | 24345826 | J Pediatr Gastroenterol Nutr | Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity. | 2014 | Details |
| A22743 | 24337650 | Semin Immunopathol | Microbiota and nonalcoholic steatohepatitis. | 2013 | Details |
| A22744 | 24336007 | Med Sci Monit | Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes. | 2013 | Details |
| A22746 | 24335764 | Int J Obes (Lond) | Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice. | 2013 | Details |
| A22747 | 24333862 | J Hepatol | A population-based study on the prevalence of NASH using scores validated against liver histology. | 2013 | Details |
| A22748 | 24333444 | Biochem Biophys Res Commun | Mechanisms underlying hypertriglyceridemia in rats with monosodium L-glutamate-induced obesity: evidence of XBP-1/PDI/MTP axis activation. | 2013 | Details |
| A22757 | 24327268 | Hepatology | Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ. | 2014 | Details |
| A22762 | 24324835 | PLoS One | Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome. | 2013 | Details |
| A22765 | 24322742 | Hepatobiliary Pancreat Dis Int | Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review. | 2013 | Details |
| A22768 | 24321532 | J Pediatr | Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A22770 | 24321090 | BMC Gastroenterol | Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice. | 2013 | Details |
| A22771 | 24320032 | Curr Pharm Des | The metabolic syndrome and chronic liver disease. | 2014 | Details |
| A22772 | 24317388 | Blood Coagul Fibrinolysis | Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease. | 2014 | Details |
| A22774 | 24316747 | Acta Cir Bras | The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors. | 2013 | Details |
| A22776 | 24316260 | Gastroenterology | Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. | 2013 | Details |
| A22782 | 24308774 | Aliment Pharmacol Ther | Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments. | 2013 | Details |
| A22784 | 24306155 | Obes Res Clin Pract | Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease. | 2014 | Details |
| A22785 | 24304731 | Rev Invest Clin | [Decrease of liver fat content by aerobic exercise or metformin therapy in overweight or obese women]. | 2014 | Details |
| A22789 | 24303464 | World J Clin Cases | Liver failure in an obese middle-aged woman after biliointestinal bypass. | 2013 | Details |
| A22790 | 24303090 | World J Hepatol | Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome. | 2013 | Details |
| A22791 | 24302697 | Pediatr Obes | Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: coincidence or comorbidity? | 2013 | Details |
| A22792 | 24302567 | Mol Nutr Food Res | Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. | 2013 | Details |
| A22797 | 24298105 | Clin Med (Lond) | Low vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults. | 2013 | Details |
| A22799 | 24295779 | Biochim Biophys Acta | Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice. | 2014 | Details |
| A22803 | 24292310 | Mymensingh Med J | Histological scoring and associated risk factors of non-alcoholic fatty liver disease. | 2013 | Details |
| A22807 | 24290319 | Rev Gastroenterol Mex | [Gut microbiota in health and disease]. | 2013 | Details |
| A22808 | 26355775 | J Clin Transl Hepatol | Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention. | 2013 | Details |
| A22809 | 26202297 | Hepatol Int | Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific. | 2013 | Details |
| A22810 | 26202295 | Hepatol Int | Lean NASH: distinctiveness and clinical implication. | 2013 | Details |
| A22811 | 26202294 | Hepatol Int | An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis. | 2013 | Details |
| A22814 | 26202291 | Hepatol Int | Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A22816 | 25841911 | Chin Clin Oncol | Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma. | 2013 | Details |
| A22819 | 24287794 | Endocrine | Non-alcoholic fatty liver disease: a diabetologist's perspective. | 2013 | Details |
| A22821 | 24285955 | Int J Endocrinol | Multidisciplinary approach to the treatment of obese adolescents: effects on cardiovascular risk factors, inflammatory profile, and neuroendocrine regulation of energy balance. | 2013 | Details |
| A22823 | 24284392 | Int J Mol Sci | Lessons from mouse models of high-fat diet-induced NAFLD. | 2013 | Details |
| A22824 | 24284369 | Eur J Gastroenterol Hepatol | Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children. | 2014 | Details |
| A22825 | 24282628 | Oxid Med Cell Longev | Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease. | 2013 | Details |
| A22828 | 24277674 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes in obese children. | 2014 | Details |
| A22829 | 24277052 | J Gastroenterol | Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. | 2013 | Details |
| A22831 | 24275711 | J Clin Gastroenterol | The prevalence of elevated alanine transaminase and its possible causes in the general Korean population. | 2014 | Details |
| A22832 | 24275555 | Biochim Biophys Acta | Peri-conceptional obesogenic exposure induces sex-specific programming of disease susceptibilities in adult mouse offspring. | 2013 | Details |
| A22833 | 24275089 | Food Chem Toxicol | Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. | 2013 | Details |
| A22836 | 24274878 | Clin Liver Dis | Host genetic variants in obesity-related nonalcoholic fatty liver disease. | 2013 | Details |
| A22838 | 24274876 | Clin Liver Dis | Obesity, nutrition, and liver disease in children. | 2014 | Details |
| A22839 | 24274875 | Clin Liver Dis | Impact of nutrition and obesity on chronic liver disease. | 2013 | Details |
| A22840 | 24274874 | Clin Liver Dis | Obesity and liver cancer. | 2013 | Details |
| A22841 | 24274872 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. | 2014 | Details |
| A22842 | 24274870 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis C. | 2013 | Details |
| A22843 | 24274869 | Clin Liver Dis | Surgical management of obesity in patients with morbid obesity and nonalcoholic fatty liver disease. | 2013 | Details |
| A22844 | 24274868 | Clin Liver Dis | Role of exercise in optimizing the functional status of patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22845 | 24274867 | Clin Liver Dis | The role of diet and nutritional intervention for the management of patients with NAFLD. | 2013 | Details |
| A22847 | 24274865 | Clin Liver Dis | Obesity and NAFLD: the role of bacteria and microbiota. | 2013 | Details |
| A22848 | 24274863 | Clin Liver Dis | The impact of obesity on liver histology. | 2013 | Details |
| A22849 | 24274862 | Clin Liver Dis | Obesity-associated nonalcoholic fatty liver disease. | 2013 | Details |
| A22850 | 24274861 | Clin Liver Dis | Obesity and liver disease: the epidemic of the twenty-first century. | 2014 | Details |
| A22853 | 24251710 | J Gastroenterol Hepatol | Role of diet and nutritional management in non-alcoholic fatty liver disease. | 2013 | Details |
| A22857 | 24251706 | J Gastroenterol Hepatol | Diet and exercise in management of obesity and overweight. | 2013 | Details |
| A22858 | 24251704 | J Gastroenterol Hepatol | Obesity and gastrointestinal liver disorders in Japan. | 2013 | Details |
| A22859 | 24251697 | J Gastroenterol Hepatol | Role of the gut microbiota in human nutrition and metabolism. | 2013 | Details |
| A22861 | 24269922 | Clin Gastroenterol Hepatol | Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin. | 2013 | Details |
| A22864 | 24268118 | J Cardiovasc Comput Tomogr | Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis. | 2013 | Details |
| A22867 | 24266914 | Med Clin North Am | Review of treatment options for nonalcoholic fatty liver disease. | 2013 | Details |
| A22869 | 24265237 | Compr Physiol | Steatosis in the liver. | 2013 | Details |
| A22870 | 24264333 | Chest | Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. | 2014 | Details |
| A22874 | 24262589 | Clin Nutr | Diets and nonalcoholic fatty liver disease: the good and the bad. | 2013 | Details |
| A22876 | 24260182 | PLoS One | The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. | 2013 | Details |
| A22879 | 24259612 | Ann Pharmacother | Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome. | 2013 | Details |
| A22880 | 24258517 | Semin Immunopathol | CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). | 2013 | Details |
| A22882 | 24256515 | Clin Endocrinol (Oxf) | Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease. | 2013 | Details |